Abstract PR008: Docetaxel and the Tumor Targeting Interleukin-12 (IL-12) PDS01ADC in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)Melissa L. Abel, Ravi A. Madan, Jennifer L. Marté et al.|Cancer Research|2026Cited by 0
Short-course (3-month) enzalutamide monotherapy in biochemically recurrent prostate cancer (BCR): Preliminary prostate specific membrane antigen tumor volume (PSMA-TV) data.Aanika Warner, Melissa Lauren Abel, Liza Lindenberg et al.|Journal of Clinical Oncology|2026Cited by 0